Uptake of the Human Papillomavirus Vaccine
Uptake of the Human Papillomavirus Vaccine
During 2007, 195 girls in the practice who were eligible for the HPV vaccine and had scheduled WCC appointments were offered the HPV vaccine during their office visit. The majority of the girls were aged 12 to 17 years (n = 153), and 42 girls were aged 18 to 21 years. During the review period, 73.3% (143/195) of the girls received the HPV vaccine during their annual WCC office visit. Uptake of the HPV vaccine in girls aged 12 to 17 years was 71.9% (110/153), and uptake of the HPV vaccine in girls aged 18 to 21 years was 78.6% (33/42). No significant difference in HPV vaccine uptake by age group was found (χ = .448, p = .503) (Table 2).
During the review period, a total of 189 girls who were eligible for the HPV vaccine and scheduled either a WCC or an episodic visit for acute or gynecological concerns received the HPV vaccine. A total of 75.7% (143/189) of the girls received the HPV vaccine at their WCC visit, and 24.3% (46/189) of the girls received the HPV vaccine at an episodic visit. Of the 46 girls with HPV vaccine uptake at an episodic visit, almost two thirds (65.2%; 30/46) were seen for non-gynecological concerns.
Dose completion rates also were examined during the review period. Of the girls with HPV vaccine uptake (n = 189), 63.5% (120/189) completed the three-dose series. Of the girls who completed the three-dose series, only 66.7% (80/120) of them did so within 12 months or less.
Results
During 2007, 195 girls in the practice who were eligible for the HPV vaccine and had scheduled WCC appointments were offered the HPV vaccine during their office visit. The majority of the girls were aged 12 to 17 years (n = 153), and 42 girls were aged 18 to 21 years. During the review period, 73.3% (143/195) of the girls received the HPV vaccine during their annual WCC office visit. Uptake of the HPV vaccine in girls aged 12 to 17 years was 71.9% (110/153), and uptake of the HPV vaccine in girls aged 18 to 21 years was 78.6% (33/42). No significant difference in HPV vaccine uptake by age group was found (χ = .448, p = .503) (Table 2).
During the review period, a total of 189 girls who were eligible for the HPV vaccine and scheduled either a WCC or an episodic visit for acute or gynecological concerns received the HPV vaccine. A total of 75.7% (143/189) of the girls received the HPV vaccine at their WCC visit, and 24.3% (46/189) of the girls received the HPV vaccine at an episodic visit. Of the 46 girls with HPV vaccine uptake at an episodic visit, almost two thirds (65.2%; 30/46) were seen for non-gynecological concerns.
Dose completion rates also were examined during the review period. Of the girls with HPV vaccine uptake (n = 189), 63.5% (120/189) completed the three-dose series. Of the girls who completed the three-dose series, only 66.7% (80/120) of them did so within 12 months or less.
